PTPN11 and liver dysplastic nodule: To evaluate whether SHP2 is involved in DN pathogenesis, we conducted Western blot analysis to determine its activity (represented as the level of phosphorylated SHP2, p-SHP2) in kidney biopsy samples of DN patients, and normal kidney biopsy samples were used as controls.